Kuehnle E

No ORCID on file · 3 papers in corpus
2026
Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy
The journal of pathology. Clinical research ·doi:10.1002/2056-4538.70091

Mirvetuximab-soravtansine (MIRV-S) is an antibody-drug conjugate targeting folate receptor alpha (FOLR1). MIRV-S is approved for the treatment of FOLR1-positive, platinum-resistant ovarian carcinoma. Patient eligibility is determined by imm…

article 2025
Effectiveness, Safety, and Patient Satisfaction of Laparoscopic Uterosacral Nerve Ablation in Terms of Pain Relief in Women with Chronic Pelvic Pain
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_62_24

Objectives: Chronic pelvic pain (CPP) is defined as intermittent or constant pain in the lower abdomen or pelvis for a duration of 6 months that is not exclusively associated with menstruation or sexual intercourse. Laparoscopic ablation of…

2024
Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colon.
The journal of pathology. Clinical research ·doi:10.1002/2056-4538.12361

Invasive lobular carcinoma (ILC) is a special breast cancer type characterized by noncohesive growth and E-cadherin loss. Focal activation of P-cadherin expression in tumor cells that are deficient for E-cadherin occurs in a subset of ILCs.…